Drug name - Fabior

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10568859 MAYNE PHARMA Topical foam composition Feb, 2030

(7 years from now)

US10688071 MAYNE PHARMA Topical foam composition Feb, 2030

(7 years from now)

US8808716 MAYNE PHARMA Topical foam composition Feb, 2030

(7 years from now)

Drugs and Companies using TAZAROTENE ingredient

Treatment: Topical treatment of acne vulgaris in patients 12 years of age or older

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.1% AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.